Jiangzhong Pharmaceutical News and Activities

Jiangzhong Pharmaceutical is a company listed under the stock ticker 600750 (CN).

View the org chart displaying its 15 main executives

Most searched biographies at Jiangzhong Pharmaceutical

• Yongqian Xu, General Manager
• Weiquan Liu, Chairman of the Board
• Henghua Xie, Independent Director

Create your alert
to follow the executive moves at Jiangzhong Pharmaceutical.

Jiangzhong Pharmaceutical has 1,914 competitors including Sanofi (France), Moderna (United States (USA)) and Eli Lilly (United States (USA)).

Popular M&A news in Pharmaceuticals

• Aurobindo has announced the acquisition of Lannett  (posted on June 26 2026).
• Merck has announced the acquisition of Bio-Techne  (posted on June 25 2026).
• Eli Lilly has acquired Centessa Pharmaceuticals (posted on June 24 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Tracey Franklin - Chief People and Digital Technology Officer at Moderna
• Richard Saynor - Chief Executive Officer at Sandoz

Learn more about the Pharmaceuticals industry

Press releases by Jiangzhong Pharmaceutical

Social media about Jiangzhong Pharmaceutical

• Jiangzhong Pharmaceutical on Wikipedia, Google News & Yahoo Finance
• Jiangzhong Pharmaceutical on LinkedIn, X (Twitter) & YouTube